Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Danshensu alleviates bleomycin-induced pulmonary fibrosis by inhibiting lung fibroblast-to-myofibroblast transition via the MEK/ERK signaling pathway
Huaman Liu, Xinyue Zhang, Yumeng Shao, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 3113-3124
Open Access | Times Cited: 24

Showing 24 citing articles:

Versatile CYP98A enzymes catalyse meta‐hydroxylation reveals diversity of salvianolic acids biosynthesis
Zheng Zhou, Jingxian Feng, Juncheng Huo, et al.
Plant Biotechnology Journal (2024) Vol. 22, Iss. 6, pp. 1536-1548
Open Access | Times Cited: 10
Molecular pathogenesis of subretinal fibrosis in neovascular AMD focusing on epithelial-mesenchymal transformation of retinal pigment epithelium
Dandan Liu, Chaoyang Zhang, Jingting Zhang, et al.
Neurobiology of Disease (2023) Vol. 185, pp. 106250-106250
Open Access | Times Cited: 22
Schisandrol A, the main active ingredient of Schisandrae Chinensis Fructus, inhibits pulmonary fibrosis through suppression of the TGF-β signaling pathway as revealed by UPLC-Q-TOF/MS, network pharmacology and experimental verification
Zhenghua Wu, Mengqi Jia, Wenjuan Zhao, et al.
Journal of Ethnopharmacology (2022) Vol. 289, pp. 115031-115031
Closed Access | Times Cited: 20
Angiopoietin-like 4 Is a Critical Regulator of Fibroblasts during Pulmonary Fibrosis Development
Shoichiro Saito, Masahiro Kitabatake, Noriko Ouji-Sageshima, et al.
American Journal of Respiratory Cell and Molecular Biology (2023) Vol. 69, Iss. 3, pp. 328-339
Closed Access | Times Cited: 13
Chinese medicine as a therapeutic option for pulmonary fibrosis: Clinical efficacies and underlying mechanisms
Yanwei Hao, Jiaxin Li, Lijuan Dan, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 116836-116836
Closed Access | Times Cited: 13
Leech extract alleviates idiopathic pulmonary fibrosis by TGF-β1/Smad3 signaling pathway
Yin Zhang, Yongbo Lu, Weijie Zhu, et al.
Journal of Ethnopharmacology (2024) Vol. 324, pp. 117737-117737
Closed Access | Times Cited: 4
Targeting tumor-derived exosome-mediated premetastatic niche formation: The metastasis-preventive value of traditional Chinese medicine
Wentao Jia, Jiaying Yuan, Binbin Cheng, et al.
Cancer Letters (2023) Vol. 567, pp. 216261-216261
Closed Access | Times Cited: 11
Sparganii Rhizoma alleviates pulmonary fibrosis by inhibiting fibroblasts differentiation and epithelial-mesenchymal transition mediated by TGF-β1/ Smad2/3 pathway
Jing Liu, Dongyang Gao, Qi Ding, et al.
Journal of Ethnopharmacology (2023) Vol. 309, pp. 116305-116305
Closed Access | Times Cited: 10
Bioinformatics-based identification of mirdametinib as a potential therapeutic target for idiopathic pulmonary fibrosis associated with endoplasmic reticulum stress
Junwei Chen, Y. W. Du, Qi Yu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Lycorine ameliorates isoproterenol-induced cardiac dysfunction mainly via inhibiting inflammation, fibrosis, oxidative stress and apoptosis
Ji Wu, Yang Fu, YingXing Wu, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 5583-5594
Open Access | Times Cited: 18
Advances in common in vitro cellular models of pulmonary fibrosis
Die Li, Xinyue Zhang, Ziqiong Song, et al.
Immunology and Cell Biology (2024) Vol. 102, Iss. 7, pp. 557-569
Open Access | Times Cited: 2
Network pharmacology and molecular docking to explore the pharmacological mechanism of Yifei Tongluo granules in treating idiopathic pulmonary fibrosis: A review
Y. Hou, Guoyu Wang, Han Shuo, et al.
Medicine (2023) Vol. 102, Iss. 22, pp. e33729-e33729
Open Access | Times Cited: 4
Tanshinone IIA ameliorates energy metabolism dysfunction of pulmonary fibrosis using 13C metabolic flux analysis
Baixi Shan, Haoyan Zhou, Congying Guo, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 14, Iss. 2, pp. 244-258
Open Access | Times Cited: 4
Molecular mechanism of Danshenol C in reversing peritoneal fibrosis: novel network pharmacological analysis and biological validation
Jiabin Liang, Lulu Cheng, Jie Feng, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
IL-38 alleviates airway remodeling in chronic asthma via blocking the profibrotic effect of IL-36γ
Min Zhang, Jian-Xia Zhou, Chuqin Huang, et al.
Clinical & Experimental Immunology (2023) Vol. 214, Iss. 3, pp. 260-274
Open Access | Times Cited: 3
Genome-wide DNA methylation analysis of Astragalus and Danshen on the intervention of myofibroblast activation in idiopathic pulmonary fibrosis
Qingyin Liu, Xue Liu, Guoyu Wang, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
The peptide DR3penA exhibits antifibrotic activity in multiple pulmonary fibrosis models induced by particulate and soluble chemical fibrogenic agents
Jieru Li, Bochuan Deng, Jiao Zhang, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 388, Iss. 2, pp. 701-714
Open Access | Times Cited: 2
Dangui Huoxue Preparation (DHP) Ameliorates Skin Fibrosis, Inflammation, and Vasculopathy in the Bleomycin‐Induced Murine Model of Systemic Sclerosis
Yue-Mei Yan, Dianyu Cao, Ji‐An Liang, et al.
Advanced Biology (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Tanshinol alleviates ischemia-induced myocardial fibrosis via targeting ERK2 and disturbing the intermolecular autophosphorylation of ERK2Thr188
Lei Wei, Chunyan Chen, Feng-jie Zhou, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115729-115729
Open Access | Times Cited: 1
Trillin Protects Against Bleomycin-Induced Pulmonary Fibrosis via Suppressing Oxidative Stress and IL-1β/NLRP3 Inflammasome Positive Cycle
Xiangyun Li, Shanshan Wei, Sa Liu, et al.
Natural Product Communications (2024) Vol. 19, Iss. 3
Open Access
Activation of the cGMP/PKG/ERK signaling pathway associated with PDE5Is inhibits fibroblast activation by downregulating autophagy in early progressive benign prostatic hyperplasia
Song Jin, Zhanliang Liu, Xiang Peng, et al.
World Journal of Urology (2024) Vol. 42, Iss. 1
Closed Access
Arbutin alleviates Mycoplasma gallinarum-induced damage caused by pulmonary fibrosis via the JAK2/STAT3 pathway
Ting Liu, Zhentao Cheng, Dongfang Song, et al.
Poultry Science (2024), pp. 104434-104434
Open Access
Research Progress on the Mechanism of Action of <i>Salvia </i><i>miltiorrhiza</i> and Its Main Components on Pulmonary Fibrosis
少琪 张
Advances in Clinical Medicine (2024) Vol. 14, Iss. 11, pp. 1228-1234
Closed Access
Advances in common in vitro cellular models of pulmonary fibrosis
Die Li, Qian Weibin, Xinyue Zhang, et al.
Authorea (Authorea) (2023)
Open Access
Page 1

Scroll to top